An international team involving Vanderbilt researchers has discovered that a new "checkpoint" protein on immune system cells is active in tumors, and that blocking it—in combination with other treatments—is a successful ...
Feb 22, 2019
0
174
Researchers from the University of Colorado Anschutz Medical Campus have identified a potential new immune checkpoint receptor that could lead to treatments for diseases such as lung and bowel cancer and autoimmune conditions ...
Jun 30, 2023
0
66
The discovery of how a vital immune cell recognises dead and damaged body cells could modernise vaccine technology by 'tricking' cells into launching an immune response, leading to next-generation vaccines that are more specific, ...
Apr 5, 2012
0
0
Researchers at the Stanford Cardiovascular Institute have discovered how viruses like influenza and SARS-CoV-2 as well as their associated vaccines may increase the risk of heart attack, stroke, heart inflammation, and other ...
May 9, 2022
0
258
Almost 300,000 people worldwide develop malignant melanoma each year. The disease is the most serious form of skin cancer and the number of cases reported annually is increasing, making skin cancer one of Sweden's most common ...
Jul 1, 2019
0
1
For the first time in the world: a team of researchers from Tel Aviv University and the Israel Institute for Biological Research have developed an mRNA-based vaccine that is 100% effective against a type of bacteria that ...
Mar 9, 2023
0
190
A team of University of Maryland researchers developed a nasal spray vaccine that delivers the SARS-CoV-2 spike protein into cells of the airway in mice and hamsters, triggering an immune response that significantly reduced ...
Nov 6, 2023
0
72
COVID-19 is caused by a coronavirus called SARS-CoV-2. Coronaviruses belong to a group of viruses that infect animals, from peacocks to whales. They're named for the bulb-tipped spikes that project from the virus's surface ...
Apr 3, 2020
0
38
The Novavax COVID-19 vaccine was approved in Germany this February, followed by the U.S. in mid-July. Immunology professor Martina Sester and her team have now studied how Novavax recipients respond to the vaccine. The study ...
Aug 11, 2022
0
4
Under the right circumstances, the body's T cells can detect and destroy cancer cells. However, in most cancer patients, T cells become disarmed once they enter the environment surrounding a tumor.
Nov 19, 2021
0
91
